RADNET, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.65 USD | +2.43% |
|
-0.33% | +37.04% |
Financials (USD)
| Sales 2024 * | 1.76B | Sales 2025 * | 1.89B | Capitalization | 3.51B |
|---|---|---|---|---|---|
| Net income 2024 * | 38M | Net income 2025 * | 56M | EV / Sales 2024 * | 2 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.85 x |
| P/E ratio 2024 * |
91.6
x | P/E ratio 2025 * |
62.7
x | Employees | 8,157 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.53% |
More Fundamentals
* Assessed data
More news
Latest transcript on RadNet, Inc.
More recommendations
More press releases
| 1 day | +2.43% | ||
| 1 week | -0.33% | ||
| Current month | -2.08% | ||
| 1 month | -0.81% | ||
| 3 months | +24.90% | ||
| 6 months | +66.43% | ||
| Current year | +37.04% |
1 week
46.18
48.46
1 month
46.0949.94
Current year
33.4449.94
1 year
25.1149.94
3 years
12.0349.94
5 years
5.8149.94
10 years
4.5749.94
| Managers | Title | Age | Since |
|---|---|---|---|
Howard Berger
CEO | Chief Executive Officer | 79 | 79-12-31 |
Mark Stolper
DFI | Director of Finance/CFO | 52 | 04-02-29 |
| Chief Tech/Sci/R&D Officer | 66 | 14-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mark Stolper
DFI | Director of Finance/CFO | 52 | 04-02-29 |
David L. Swartz
BRD | Director/Board Member | 80 | 03-12-31 |
| Director/Board Member | 81 | 04-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.22% | 45 M€ | -0.94% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 47.65 | +2.43% | 364,092 |
| 24-04-19 | 46.52 | -2.29% | 594,495 |
| 24-04-18 | 47.61 | -0.40% | 421,329 |
| 24-04-17 | 47.8 | -0.19% | 408,012 |
| 24-04-16 | 47.89 | +0.17% | 442,229 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotes
RadNet, Inc. is a national provider of fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States. It has a network of 366 owned and/or operated outpatient imaging centers. The Companyâs Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Companyâs Artificial Intelligence (AI) segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate and pulmonary diagnostics. The Company, through its joint ventured Arizona Diagnostic Radiology Group, LLC, owns seven outpatient imaging centers.
Calendar
2024-05-07
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
47.65
USD
Average target price
53.33
USD
Spread / Average Target
+11.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +37.04% | 3.51B | |
| -16.30% | 8.18B | |
| -28.32% | 2.9B | |
| -7.53% | 2.47B | |
| -12.81% | 2.25B | |
| -17.06% | 1.71B | |
| -22.34% | 1.47B | |
| -39.86% | 1.22B | |
| -10.74% | 1.09B | |
| +6.64% | 1.1B |
- Stock Market
- Equities
- RDNT Stock
